Doxycycline for Community Treatment of Suspected COVID-19 in People at High Risk of Adverse Outcomes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Respiratory Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Doxycycline for Community Treatment of Suspected COVID-19 in People at High Risk of Adverse Outcomes in the UK (PRINCIPLE): A Randomised, Controlled, Open-Label, Adaptive Platform Trial
Lancet Respir Med 2021 Jul 27;[EPub Ahead of Print], CC Butler, LM Yu, J Dorward, O Gbinigie, G Hayward, BR Saville, O Van Hecke, N Berry, MA Detry, C Saunders, M Fitzgerald, V Harris, R Djukanovic, S Gadola, J Kirkpatrick, S de Lusignan, E Ogburn, PH Evans, NPB Thomas, MG Patel, FDR HobbsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.